WS016, a novel potassium binder: safety, tolerability and pharmacodynamics in first-in-human phase 1 healthy volunteer study

被引：0
|
作者：
Zhang, Faming [1 ]
Song, Aiyun [1 ]
Fu, Min [1 ]
Zhou, Youcheng [1 ]
Hu, Minglong [1 ]
机构：
[1] Waterstone Pharmaceut Wuhan Co LTD, Wuhan, Peoples R China
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
2341
引用
收藏
页码：I1149 / I1151
页数：3
相关论文
共 50 条
  • [41] A Phase 1 first-in-human study of the safety, tolerability, and pharmacokinetics of the ROBO2 fusion protein PF-06730512 in healthy participants
    Lim, Chay Ngee
    Kantaridis, Constantino
    Huyghe, Isabelle
    Gorman, Donal
    Berasi, Stephen
    Sonnenberg, Gabriele E.
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (04):
  • [42] A First-in-Human Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Polyethylene Glycol-Erythropoietin Injection, RD01, in Healthy Volunteers
    Hu, Chaoying
    Li, Jian
    Sun, Wanling
    Zhang, Lan
    BLOOD, 2022, 140 : 2447 - 2448
  • [43] A First-in-Human Single- and Multiple-Ascending Dose Study Evaluating Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Novel Oral Nonpeptide GLP-1 Receptor Agonist in Healthy Subjects
    Pratt, Edward J.
    Ma, Xiaosu
    Liu, Rong
    Robins, Deborah A.
    Sloop, Kyle
    Benson, Charles
    DIABETES, 2022, 71
  • [44] Single-Dose, First-in-Human Study of AMG 853: Pharmacokinetics, Pharmacodynamics, and Safety in Healthy Adults
    Banfield, C.
    Parnes, J.
    Emery, M.
    Ni, L.
    Zhang, N.
    Hodsman, P.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB66 - AB66
  • [45] Single-Dose, First-in-Human Study of AMG 853: Pharmacokinetics, Pharmacodynamics, and Safety in Healthy Adults
    Banfield, C.
    Parnes, J.
    Emery, M.
    Ni, L.
    Zhang, N.
    Hodsman, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [46] A Phase 1 First-in-human Study to Investigate the Safety, Tolerability and Food Effect of ABBV-CLS-7262
    Cho, William
    Jeong, Anna
    Malik, Paul
    Boiser, Joey
    Huang, Xiu
    Rosebraugh, Matthew
    NEUROLOGY, 2023, 100 (17)
  • [47] A First-in-human Study in Healthy Volunteers Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5055, A Novel Oral Porcupine Inhibitor Under Development as a Treatment for Pulmonary Fibrosis
    Owen, C. A.
    Zhou, X.
    Sobande, O.
    Ferrari, N.
    Hezaveh, K.
    Nemes, S.
    Sosnowski, M.
    Ringqvist, K. Enarsson
    E., L.
    Mo, J.
    Gottfridsson, C.
    Platt, A.
    Brohawn, Z.
    Gochuico, B.
    Wall, G.
    Williams, M. L.
    Belvisi, M. G.
    Keen, C.
    Prothon, S.
    Goldwater, R.
    Hornberg, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [48] Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study
    Playford, Elliott Geoffrey
    Munro, Trent
    Mahler, Stephen M.
    Elliott, Suzanne
    Gerometta, Michael
    Hoger, Kym L.
    Jones, Martina L.
    Griffin, Paul
    Lynch, Kathleen D.
    Carroll, Heidi
    El Saadi, Debra
    Gilmour, Margaret E.
    Hughes, Benjamin
    Hughes, Karen
    Huang, Edwin
    de Bakker, Christopher
    Klein, Reuben
    Scher, Mark G.
    Smith, Ina L.
    Wang, Lin-Fa
    Lambert, Stephen B.
    Dimitrov, Dimiter S.
    Gray, Peter P.
    Broder, Christopher C.
    LANCET INFECTIOUS DISEASES, 2020, 20 (04): : 445 - 454
  • [49] CHK-336, A FIRST-IN-CLASS ORALLY ADMINISTERED LDH INHIBITOR: SAFETY, PK AND TARGET ENGAGEMENT IN A FIRST-IN-HUMAN PHASE 1 HEALTHY VOLUNTEER STUDY
    Tong, Vincent
    Schwartz, Brian
    Lam, Chun
    Knight, John
    Fargue, Sonia
    Wagner, David A.
    Wong, Harvey
    Wang, Lei
    Kocinsky, Hetal
    Fauvelle, Valerie
    King, Andrew
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I11 - I11
  • [50] A First-In-Human, Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Ketamine in Healthy Volunteers
    Silman, Daniel
    Gadelrab, Romayne
    Qureshi, Mutahira
    Stein, Hans
    Mehta, Mitul
    Carmelline, Pietro
    Young, Allan
    Reilly, Carmel
    Duncan, Graeme
    Juruena, Mario
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 155 - 155
12345